[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Sanofi-Aventis SpA in Consumer Health (Italy)

September 2016 | 2 pages | ID: S59FA69F01EEN
Euromonitor International Ltd

US$ 150.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Sanofi-Aventis plans to invest heavily in new product development in the forecast period, aiming to launch two new drugs a year over 2016-2018. The company will however focus new product development on Rx medicines, with a focus on rare diseases, diabetes, cardiovascular diseases and immunology. Within consumer health, the company is meanwhile likely to focus on growing sales in vitamins and dietary supplements, where it is likely to slowly expand its range in line with changing consumer needs.

Euromonitor International Local Company Profiles are a concise set of briefings detailing the strategic direction taken by a company. Discover key contact details, the company background and their competitive positioning through this collection of snapshot company profiles.

Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Consumer Health market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Strategic Direction
Key Facts
  Summary 1 Sanofi-Aventis SpA: Key Facts
Competitive Positioning
  Summary 2 Sanofi-Aventis SpA: Competitive Position 2016














More Publications